Radiologically isolated syndrome: 5-year risk for an initial clinical event

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Okuda, Darin T ^a   Siva, Aksel ^b   Kantarci, Orhun ^c   Inglese, Matilde ^d   Katz, Ilana ^d   Tutuncu, Melih ^b   Keegan, B Mark ^c   Donlon, Stacy ^e   Hua, Le H ^f   Vidal Jordana, Angela ^g   Montalban, Xavier ^g   Rovira, Alex ^g   Tintoré, Mar ^g   Amato, Maria Pia ^h   Brochet, Bruno ⁱ   De Seze, Jérôme ^j   Brassat, David ^k   Vermersch, Patrick ^l   De Stefano, Nicola ^m   Sormani, Maria Pia ⁿ   Pelletier, Daniel ^o   Lebrun, Christine ^p   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Mayo Clinic College of Medicine   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e BARROW NEUROLOGICAL INSTITUTE   (United States)

^f CLEVELAND CLINIC LOU RUVO CENTER FOR BRAIN HEALTH   (United States)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^k CHU PURPAN   (France)

^l Universitaire Claude Huriez   (France)

^m UNIVERSITY OF SIENA   (Italy)

ⁿ UNIVERSITY OF GENOA   (Italy)

^o YALE UNIVERSITY   (United States)

^p PASTEUR HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CERVICAL SPINAL CORD INJURY; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; DATA BASE; DEMYELINATING DISEASE; DISEASE COURSE; ETHNICITY; FEMALE; FRANCE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; RADIOLOGICALLY ISOLATED SYNDROME; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX; SPAIN; THORACIC SPINAL CORD LESION; TURKEY (REPUBLIC); UNITED STATES; DEMYELINATING DISEASES; DISEASE FREE SURVIVAL; INCIDENTAL FINDING; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SPINAL CORD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; DEMYELINATING DISEASES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENTAL FINDINGS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL CORD; YOUNG ADULT;

EID: 84897134823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090509     Document Type: Article

References (29)

1. Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, et al. (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72: 800-805.
2. Lebrun C, Bensa C, Debouverie M, De Seze J, Wiertlievski S, et al. (2008) Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 79: 195-198. (Pubitemid 351236555)
3. Siva A, Saip S, Altintas A, Jacob A, Keegan BM, et al. (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15: 918-927.
4. Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J, et al. (2010) Cognitive function in radiologically isolated syndrome. Mult Scler 16: 919-925.
5. De Stefano N, Stromillo ML, Rossi F, Battaglini M, Giorgio A, et al. (2011) Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One 6: e19452.
6. Gabelic T, Radmilovic M, Posavec V, Skvorc A, Boskovic M, et al. (2012) Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome. Acta Neurol Belg.
7. Giorgio A, Stromillo ML, Rossi F, Battaglini M, Hakiki B, et al. (2011) Cortical lesions in radiologically isolated syndrome. Neurology 77: 1896-1899.
8. Gabelic T, Ramasamy DP, Weinstock-Guttman B, Hagemeier J, Kennedy C, et al. (2013) Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Multiple Sclerosis Patients. AJNR Am J Neuroradiol.
9. Stromillo ML, Giorgio A., Rossi F., Battaglini M., Hakiki B., Malentacchi G., Santangelo M., Gasperini C., Bartolozzi M.L., Portaccio E., Amato M.P., De Stefano, N. (2013) Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology.
10. Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, et al. (2009) Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 66: 841-846.
11. Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, et al. (2012) Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler 18: 1297-1302.
12. Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, et al. (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76: 686-692.
13. Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30: 129-136.
14. Liu S, Kullnat J, Bourdette D, Simon J, Kraemer DF, et al. (2013) Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler 19: 1101-1105.
15. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
16. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, et al. (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357: 1821-1828. (Pubitemid 350044802)
17. Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9: 520-532.
18. Scalfari A, Neuhaus A, Daumer M, Ebers GC, Muraro PA (2011) Age and disability accumulation in multiple sclerosis. Neurology 77: 1246-1252.
19. Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126: 770-782. (Pubitemid 36372978)
20. Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, et al. (2013) Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler 19: 188-198.
21. Cohen AB, Neema M, Arora A, Dell'oglio E, Benedict RH, et al. (2012) The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging 22: 122-128.
22. Oh J, Saidha S, Chen M, Smith SA, Prince J, et al. (2013) Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology.
23. Bot JC, Barkhof F, Lycklama a Nijeholt G, van Schaardenburg D, Voskuyl AE, et al. (2002) Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223: 46-56. (Pubitemid 34258189)
24. Sombekke MH, Wattjes MP, Balk LJ, Nielsen JM, Vrenken H, et al. (2013) Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis. Neurology 80: 69-75.
25. Tintore M, Rovira A, Arrambide G, Mitjana R, Rio J, et al. (2010) Brainstem lesions in clinically isolated syndromes. Neurology 75: 1933-1938.
26. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, et al. (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343: 898-904.
27. Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, et al. (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 374: 1503-1511.
28. Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, et al. (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67: 1242-1249. (Pubitemid 44563835)
29. McDonnell GV, Cabrera-Gomez J, Calne DB, Li DK, Oger J (2003) Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years. Mult Scler 9: 204-209. (Pubitemid 36426995)